Global News

Scott Treiber to head biopharmaceutical development for Theorem Clinical Research

Thursday, May 7, 2015 11:47 AM

Global CRO Theorem Clinical Research has selected Scott P. Treiber, Ph.D., MBA, to spearhead biopharmaceutical development as executive vice president and general manager. 

More... »

Quest Diagnostics

Alexion to acquire Synageva

Wednesday, May 6, 2015 02:56 PM

Cheshire, Conn.-based Alexion Pharmaceuticals will acquire Synageva, a biopharmaceutical company based in Lexington, Mass., for $115 in cash and 0.6581 Alexion shares for each share of Synageva, implying a total per share value of $230 based on the nine-day volume-weighted average closing price of Alexion stock through May 5.

More... »

ACRES, San Antonio Express-News launch blog on accountability in clinical research

Wednesday, May 6, 2015 02:55 PM

The Alliance for Clinical Research Excellence and Safety (ACRES), a Massachusetts-based nonprofit, and Texas-based San Antonio Express-News, an affiliate of Hearst Communications, have formed a strategic alliance to create a blog as a vehicle for public outreach and education across the healthcare and clinical research endeavor. The blog provides an opportunity for the voice of patients and the public to be clearly heard in this important dialogue.

More... »

Report: Total global spending on oncology medicines reached $100B in 2014

Wednesday, May 6, 2015 02:53 PM

Earlier diagnosis, longer treatment duration and increased effectiveness of drug therapies are contributing to rising levels of spending on medicines for cancer care, according to a new report released by the IMS Institute for Healthcare Informatics, a global information and technology services company based in Parsippany, N.J. The report stated total global spending on oncology medicines—including therapeutic treatments and supportive care—reached the $100 billion threshold in 2014, even as the share of total medicine spending of oncologics increased only modestly.

More... »

Medidata launches open-source connector linking Apple ResearchKit to Medidata Clinical Cloud

Wednesday, May 6, 2015 02:52 PM

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, has completed an open-source connector linking Apple ResearchKit with the Medidata Clinical Cloud platform. This mechanism will enable life sciences companies and academic institutions to map data generated by ResearchKit apps into Medidata's secure, regulatory-compliant environment, integrating the data with other information collected in clinical trials.

More... »

Teva provides additional detail on proposed acquisition of Mylan

Wednesday, May 6, 2015 02:51 PM

Teva Pharmaceutical Industries has released an updated investor presentation in connection with its proposed combination with Mylan, which will be filed with the Securities and Exchange Commission (SEC).

More... »

Flagship Ventures partners with AstraZeneca, Nestlé, Bayer

Wednesday, May 6, 2015 02:48 PM

Flagship Ventures, a venture capital and venture creation firm focused on innovations in healthcare and sustainability, has formed strategic innovation partnerships with AstraZenecaNestlé Health Science and Bayer CropScience. These collaborations will allow Flagship to scale up its unique innovation foundry, VentureLabs, as well as expand its early stage venture funding activities while leveraging the partners' strengths as market leaders.

More... »

OPKO Health acquires EirGen Pharma

Wednesday, May 6, 2015 02:46 PM

OPKO Health, a multinational biopharmaceutical and diagnostics company, has acquired EirGen Pharma, a specialty pharmaceutical company focused on the development and commercial supply of high-potency, high-barrier-to-entry pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries and more than 40 others around the world.

More... »

Tobira Therapeutics completes merger with Regado Biosciences

Wednesday, May 6, 2015 02:45 PM

Tobira Therapeutics, a clinical-stage biopharmaceutical company focused on the development and commercialization of novel treatments for liver and immuno-inflammatory diseases, has merged with Regado Biosciences. Tobira raised $40 million of common stock from a combination of new investors and all current Tobira institutional investors, including the previously announced $13 million in debt that converted to common stock in this closing. Together with approximately $33 million net cash on Regado's balance sheet, the combined company has approximately $70 million in cash to advance clinical development of first-in-class dual CCR2/CCR5 inhibitor cenicriviroc (CVC), which is being evaluated in the phase IIb CENTAUR clinical trial for the treatment of patients with non-alcoholic steatohepatitis (NASH) and liver fibrosis.

More... »

ArQule, Beryllium collaborate

Wednesday, May 6, 2015 02:44 PM

ArQule, a Woburn, Mass.-based biotechnology company, and Beryllium Discovery, a company using target-centric platforms to provide research services and collaborations to commercial and academic partners, have formed a collaborative R&D agreement to identify and unlock the therapeutic potential of small molecule compounds by combining ArQule’s chemistry and drug development experience with Beryllium’s discovery platforms. The Beryllium platforms integrate structure-guided drug discovery, biophysics and cell biology.

More... »



May 18

Research for All Act reaches Congress for second time seeking gender equality in basic research, clinical trials

MediciGlobal finds fewer trial dropouts among participants who actively pursue enrollment versus those recruited

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs